nuvationbio
The AD/Director of Analytical Development leads the development, tracking, and progression of analytical activities for raw material, drug substance, and drug product testing across all stages of development through commercial support. This role oversees in‑process, release, and stability testing, manages third‑party vendors, and ensures alignment with global analytical strategies and regulatory requirements.
Headquarters
New York, New York, United States
Company Size
51-200 employees
Founded
2018
NUVATION BIO, INC. is a global oncology company driven by science, focused on tackling some of the toughest challenges in cancer treatment. The company aims to discover and develop novel cancer therapies by leveraging translational science and a disciplined, data-driven approach to build a robust pipeline. Led by founder and Chief Executive Officer David Hung, M.D., Nuvation Bio pursues strategic collaborations and rigorous development to deliver meaningful clinical outcomes for patients. Its mission centers on advancing transformative oncology programs through rigorous research, partnerships, and patient-centric priorities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for nuvationbio.
nuvationbio didn’t post a salary, so this is our estimate from similar listings.
38% below the average for this role
Analytical Development Scientist
BridgeBio Pharma
Principal Analytical QA Specialist, Drug Substance
Loyal
Associate Director/Principal Scientist, CMC Analytical Chemistry
Latigobio
Director, Analytical Services
Harrow, Inc.
Senior Scientist, Analytical Chemistry
Careers board
Senior Scientist, Analytical Chemistry
HCFA Global